tzield - teplizumab - mzwv injection
(Teplizumab-Mzwv)Provention Bio, Inc.
Usage: Tzield delays the onset of Stage 3 type 1 diabetes in adults and children 1 year and older with Stage 2 T1D. It also delays the decline in endogenous insulin production in pediatric patients aged 8 to 17 years recently diagnosed with Stage 3 T1D.